FDA label
What is Xcopri used for?
Xcopri contains cenobamate. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “XCOPRI is indicated for the treatment of partial-onset seizures in adult patients.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Xcopri?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Xcopri, tablet, film coated
Indications and Usage, quoted from the label by SK Life Science, Inc. (NDA212839). Cross-references to other label sections are left out.
XCOPRI is indicated for the treatment of partial-onset seizures in adult patients.
Source: DailyMed label, set id 565c2126-57ae-4e29-b443-723bbe7e2072, version 46, effective August 25, 2025. NDC 71699-025, one of 5 listings for this product.
Questions
What is Xcopri used for?
The FDA label says: “XCOPRI is indicated for the treatment of partial-onset seizures in adult patients.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.